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Differential Features of Culprit Intracranial Atherosclerotic Lesions:
A Whole-Brain Vessel Wall Imaging Study in Patients With Acute
Ischemic Stroke
Fang Wu, MD;* Qingfeng Ma, MD;* Haiqing Song, MD; Xiuhai Guo, MD; Marcio A. Diniz, PhD; Shlee S. Song, MD; Nestor R. Gonzalez, MD;
Xiaoming Bi, PhD; Xunming Ji, MD; Debiao Li, PhD; Qi Yang, MD; Zhaoyang Fan, PhD; on behalf of the WISP Investigators**
Background-—Intracranial atherosclerotic disease tends to affect multiple arterial segments. Using whole-brain vessel wall
imaging, we sought to study the differences in plaque features among various types of plaques in patients with a recent unilateral
anterior circulation ischemic stroke.
Methods and Results-—Sixty-one patients with unilateral anterior circulation ischemic stroke were referred to undergo whole-brain
vessel wall imaging (before and after contrast) within 1 month of symptom onset for intracranial atherosclerotic disease
evaluations. Each plaque was classified as a culprit, probably culprit, or nonculprit lesion, according to its likelihood of causing the
stroke. The associations between plaque features (thickening pattern, plaque-wall contrast ratio, high signal on T1-weighted
images, plaque contrast enhancement ratio, enhancement grade, and enhancement pattern) and culprit lesions were estimated
using mixed multivariable logistic regression after adjustment for maximum wall thickness. In 52 patients without motion
corruption in whole-brain vessel wall imaging, a total of 178 intracranial plaques in the anterior circulation were identified, including
52 culprit lesions (29.2%), 51 probably culprit lesions (28.7%), and 75 nonculprit lesions (42.1%). High signal on T1-weighted
images (adjusted odds ratio, 9.1; 95% confidence interval, 1.9–44.1; P=0.006), grade 2 (enhancement ratio of plaque ≥
enhancement ratio of pituitary) contrast enhancement (adjusted odds ratio, 17.4; 95% confidence interval, 1.8–164.9; P=0.013),
and type 2 (≥50% cross-sectional wall involvement) enhancement pattern (adjusted odds ratio, 10.1; 95% confidence interval, 1.3–
82.2; P=0.030) were independently associated with culprit lesions.
Conclusions-—High signal on T1-weighted images, grade 2 contrast enhancement, and type 2 enhancement pattern are associated
with cerebrovascular ischemic events, which may provide valuable insights into risk stratification. ( J Am Heart Assoc. 2018;7:
e009705. DOI: 10.1161/JAHA.118.009705.)
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I ntracranial atherosclerotic disease (ICAD) is one of themost common causes of stroke worldwide, with partic-
ularly high prevalence in Asians, Hispanics, and Africans.1–5
ICAD tends to affect multiple arterial segments.6 Despite
the same genetic milieu and acquired factors, the coexisting
atherosclerotic plaques in a given patient exhibit different
outcomes; some lesions become symptomatic, whereas
others remain asymptomatic.7 This fact brings 2 critical
challenges in the management of patients with ICAD: the
identification of the symptomatic or culprit lesion in
symptomatic patients and the identification of the vulner-
able (or high risk for causing a stroke) plaque in asymp-
tomatic patients. The solution currently available to
clinicians heavily relies on luminography imaging, with
which the stenotic degree is a primary criterion for defining
a culprit or high-risk lesion. However, extensive research on
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the atherosclerosis disease has suggested that lumen
narrowing may not be a reliable indicator of plaque severity
because of positive remodeling of the vessel wall,8 and the
features exhibited directly by plaques may provide comple-
mentary information.9,10
Intracranial magnetic resonance (MR) vessel wall imaging
(VWI) has emerged as a noninvasive modality for directly
characterizing ICAD.10 The advent of 3-dimensional VWI
techniques in the past few years also makes it possible to
simultaneously assess atherosclerotic plaques presenting in
multiple arterial segments.11,12 Using VWI, several plaque
features have been intimately associated with symptomatic or
asymptomatic lesions, such as high signal on T1-weighted
images (HST1), wall thickening pattern, and postcontrast
enhancement.7,13–18 However, most of previous studies were
limited to one feature only, a local arterial segment, or a
cohort with heterogeneous time periods after symptom onset.
Targeting a homogeneously acute stroke patient cohort and
understanding the differences in a group of plaque features
between symptomatic and asymptomatic lesions may yield an
enhanced ability to identify the culprit or high-risk lesion, thus
providing more clinically relevant insights into risk stratifica-
tion and treatment decision.19
The present study sought to use a recently developed
whole-brain 3-dimensional VWI technique (WB-VWI) to assess
a cohort of patients with a recent unilateral anterior
circulation ischemic stroke. The technique, based on sampling
perfection with application-optimized contrast using different
flip angle evolutions, coupled with nonselective excitation and
a trailing magnetization flip-down module, has demonstrated
improved spatial coverage, T1 contrast weighting, and signal
suppression of cerebrospinal fluid. In principle, these all favor
the delineation of the aforementioned plaque features.20,21
The atherosclerotic lesions in all large intracranial arteries
involved in bilateral anterior circulation were investigated to
reveal the plaque features that are highly associated with
symptomatic lesions.
Methods
The data that support the findings of this study are available
from the corresponding author on reasonable request.
Patients
The study was approved by the Ethics Committee of
Xuanwu Hospital of Capital Medical University (Beijing,
China), and informed consent was obtained from all
patients or patient guardians. From October 2015 to June
2017, patients who were admitted to the stroke center of
our hospital were prospectively recruited into this study if
they had the following: (1) unilateral ischemic stroke in the
territory of the anterior circulation within the past 30 days;
(2) at least one ≥50% intracranial stenosis within the
vascular territory of the stroke, as confirmed by MR
angiography, computed tomography angiography, or digital
subtraction angiography; or (3) at least one atherosclerotic
risk factor, including hypertension, diabetes mellitus,
hyperlipidemia, and cigarette smoking. Exclusion criteria
were as follows: (1) contraindications to MR and gadolin-
ium-based contrast agents; (2) history of strokes or
transient ischemic attacks in the contralateral anterior
circulation territory; (3) coexistent ≥50% ipsilateral extracra-
nial carotid artery stenosis; (4) nonatherosclerosis vascu-
lopathy (eg, dissection, vasculitis, or Moyamoya disease);
(5) evidence of cardioembolism; and (6) history of trans-
luminal intervention.
Clinical information, including sex, age, body mass index,
systolic blood pressure, diastolic blood pressure, total
cholesterol, low-density lipoprotein, high-density lipoprotein,
current smoking, and onset to WB-VWI time, was recorded for
each patient.
Imaging Protocol
Imaging was performed on a 3-T system (Magnetom Verio;
Siemens, Erlangen, Germany) equipped with a standard 32-
channel head coil. The protocol consisted of 3-dimensional
time-of-flight MR angiography and precontrast and postcon-
trast 3-dimensional T1-weighted WB-VWI. Imaging parameters
for WB-VWI were as follows: repetition time/echo time, 900/
15 ms; field of view, 1709170 mm2; 240 slices; voxel size,
0.5390.5390.53 mm3 without any interpolation; and scan
time, 8 minutes. Postcontrast WB-VWI was performed 5 min-
utes after the injection of single-dose (0.1 mmol/kg of body
weight) gadolinium-based contrast agent (Magnevist; Scher-
ing, Berlin, Germany).
Clinical Perspective
What Is New?
• A recently developed whole-brain 3-dimensional vessel wall
imaging technique was used in our study because of its
improved spatial coverage, T1 contrast weighting, and signal
suppression of cerebrospinal fluid.
• We identified the significant differences in plaque features
among culprit/probably culprit/nonculprit lesions.
What Are the Clinical Implications?
• Our results provide strong evidence on further research into
the potential of these features as important imaging
markers for better risk stratification and decision making
for early intervention.
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Image Analysis
Commercial software (OsirixMD; PixmeoSARL, Bernex, Switzer-
land) with 3-dimensional multiplanar reformation was used for
image analysis. Source images and reformatted longitudinal and
cross-sectional views were all available to readers.
WB-VWI images were first evaluated by an experienced
neuroradiologist (F.W.) who was blinded to the identity and
clinical information of patients. All large intracranial internal
arteries of bilateral anterior circulation, including the intracra-
nial internal carotid artery, middle cerebral artery (up to the
M3 segment), and anterior cerebral artery, were inspected for
the presence of atherosclerotic plaques by longitudinal and
cross-sectional views. A plaque was defined as wall thickening
on the cross-sectional view of a segment using its adjacent
proximal, distal, or contralateral vessel segment as a refer-
ence. The thickening pattern was visually categorized as type
1 (<50% cross-sectional wall involvement) or type 2 (≥50%
cross-sectional wall involvement).
Quantitative and qualitative evaluations were performed on
the cross-sectional views of individual lesions. Mean signal
intensity (SI) was quantified with manually drawn regions of
interest. The mean SIs of the brightest region within each
identified atherosclerotic lesion and the SI of the reference
normal vessel wall were measured on precontrast images. The
ratio of these 2 measurements, named plaque-wall contrast
ratio (CR), was calculated. A plaque with the HST1 feature was
identified if its plaque-wall CR >150%. In addition, mean SI
was quantified in each of plaques at their most thickened
cross sections and also in their adjacent reference normal
vessel wall, brain parenchyma, and the pituitary infundibu-
lum on both precontrast and postcontrast images. Con-
trast enhancement ratio (ER), calculated as SIpostcontrast/
SIprecontrast9100%, was determined for the plaque, reference
wall, and pituitary infundibulum, where SIprecontrast and
SIpostcontrast were the specific tissue’s SI normalized by the
SI of adjacent brain parenchyma on precontrast and post-
contrast images, respectively.15 The degree of lesion
enhancement was graded as follows: grade 0, plaque ER ≤
reference wall ER; grade 1, reference wall ER < plaque ER <
pituitary infundibulum ER; grade 2, plaque ER ≥ pituitary
infundibulum ER. The enhancement pattern was also visually
categorized as type 1 (<50% cross-sectional wall involvement)
or type 2 (≥50% cross-sectional wall involvement). In addition,
maximum wall thickness was measured manually at the most
thickened location of each plaque on the cross-sectional
precontrast images. The stenosis degree was defined as
follow: 1(lesion lumen area/reference lumen area)9100%.
The stenosis degree was visually graded: 1, <25%; 2, 25% to
49%; 3, 50% to 74%; and 4, ≥75%.
A subgroup of patients (n=20) were included to study the
reproducibility of the above quantitative measurements. A
second observer performed quantification for assessing
interobserver agreement, and observer 1 requantified the
measures 8 weeks after the first reading session for assess-
ing intraobserver agreement.
All detected atherosclerotic lesions were classified into 3
groups (culprit, probably culprit, and nonculprit), according to
their likelihood of causing the stroke by 2 independent
neurologists (Q.M., H.S.). They were provided each patient’s
clinical history, routine brain MR, angiographic images, and
plaque locations, as determined by neuroradiologists (F.W.,
Q.Y.), but had no access to VWI data to avoid influence of their
decision by postcontrast wall enhancement. A culprit lesion
was defined as the following: (1) the only lesion within the
vascular territory of the stroke or (2) the most stenotic lesion
when multiple plaques were present within the same vascular
territory of the stroke.15 A lesion was considered probably a
culprit plaque if it was within the same vascular territory of the
stroke but was not the most stenotic lesion.15 A lesion was
deemed a nonculprit plaque when it was not within the vascular
territory of the stroke.15 Any disagreements between the 2
reviewers were resolved with discussion and consensus.
Statistical Analysis
All continuous variables were expressed as meansSDs, and
categorical variables were summarized as counts (percent-
ages). The differences in stenosis degree and plaque features
(thickening pattern, plaque-wall CR, HST1, plaque ER,
enhancement grade, and enhancement pattern) among
culprit, probably culprit, and nonculprit lesions were com-
pared using a likelihood test between logistic models, with
pairwise comparisons corrected using Holm correction. Odds
ratios (ORs) of culprit (versus probably culprit or nonculprit
lesions) with their respective 95% confidence intervals (CIs)
were assessed using mixed multivariable logistic regression,
with plaque features as covariates, and adjusted by maximum
wall thickness. Random effects to describe multiple lesions in
the same patient were used. Intraobserver and interobserver
agreements in quantitative measurements were assessed by
intraclass correlation coefficients, with a 1-way random effect
for intraobserver continuous variables and a 2-way random
effect for interobserver continuous variables. P<0.05 indi-
cated statistical significance. All statistical analyses were
performed by using SPSS, version 22.0 (IBM, Armonk, NY) and
R, version 3.4.1.
Results
Patient Characteristics
Among the 61 patients who were recruited and scanned, 9
were excluded because of poor-quality WB-VWI images,
DOI: 10.1161/JAHA.118.009705 Journal of the American Heart Association 3
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caused by motion artifacts during either precontrast or
postcontrast scans. A total of 52 patients (35 men and 17
women; mean age, 49.411.6 years) were finally included for
analyses. The median interval between symptom onset and
WB-VWI was 11.97.3 days (range, 1–30 days). All patients
had positive findings on diffusion-weighted imaging
sequences. Patient demographics and main atherosclerosis
risk factors are summarized in Table 1.
Plaque Location and Classification
A total of 178 intracranial atherosclerotic lesions were
identified in the 52 patients, with multiple lesions seen in
48 (92.3%). Of these lesions, 27 (15.2%) were found in the
intracranial carotid artery, 148 (83.1%) were found in the
middle cerebral artery, and 3 (1.7%) were found in the anterior
cerebral artery (Table 2). A total of 107 lesions (60.1%) were
located on the symptomatic side, and 71 (39.9%) were located
on the asymptomatic side. A total of 52 lesions (29.2%) were
deemed culprit lesions, 51 (28.7%) were deemed probably
culprit lesions, and 75 (42.1%) were deemed nonculprit
lesions.
Plaque Features in the 3 Lesion Types
The details of plaque features in the 3 lesion types are
described in Table 3. The incidence of type 2 thickening
pattern was significantly higher (P<0.001 for both) in culprit
lesions (76.9%) than in probably culprit lesions (29.4%) and
nonculprit lesions (18.7%). The wall thickening pattern
showed no difference between probably culprit lesions and
nonculprit lesions (P=0.162).
HST1 occurred in 75.0% of culprit lesions, 23.5% of
probably culprit lesions, and 33.3% of nonculprit lesions.
Compared with probably culprit lesions (P<0.001) and
nonculprit lesions (P<0.001), culprit lesions were more
presented with HSTI. The incidence of HST1 was not different
between probably culprit lesions and nonculprit lesions
(P=0.232). Plaque-wall CR was significantly higher (P<0.001
for both) in culprit lesions (2.01.0) than in probably culprit
lesions (1.40.4) and nonculprit lesions (1.40.4), and it was
similar between probably culprit and nonculprit lesions
(P=0.712) (Figure 1A). A representative case is shown in
Figure 2.
The degree of contrast enhancement of culprit lesions
(44.2%, grade 1; and 50.0%, grade 2) was significantly
different from that of probably culprit lesions (58.8%, grade
1; and 17.7%, grade 2; P=0.001) and nonculprit lesions
(68.0%, grade 1; and 4.0%, grade 2; P<0.001). The enhance-
ment degree was also different between probably culprit
lesions and nonculprit lesions (P=0.038). Plaque ER was
significantly higher (P<0.001 for both) in culprit lesions
(1.80.6) than in probably culprit lesions (1.40.5) and
nonculprit lesions (1.20.3), and it was also significantly
different between probably culprit and nonculprit lesions
(P=0.006) (Figure 1B).
The incidence of type 2 enhancement pattern was
significantly higher (P<0.001 for both) in culprit lesions
(73.1%) than in probably culprit lesions (21.6%) and nonculprit
lesions (10.7%). The enhancement pattern showed no differ-
ence between probably culprit lesions and nonculprit lesions
(P=0.096). A representative case is shown in Figure 3.
Associations of Plaque Features With Culprit
Lesions
After adjustment by maximum wall thickness, type 2 thick-
ening pattern (OR, 12.4; 95% CI, 3.9–39.1; P<0.001), HST1
Table 1. Patient Characteristics
Characteristics Values
No. of patients* 52
Age, y 49.411.6
Male sex* 35 (67.3)
Body mass index, kg/m2 26.13.4
Systolic blood pressure, mm Hg 143.217.2
Diastolic blood pressure, mm Hg 84.510.7
Total cholesterol, mmol/L 3.81.2
LDL cholesterol, mmol/L 2.00.9
HDL cholesterol, mmol/L 1.10.3
Current smoker* 25 (48.1)
Onset to WB-VWI time, d 11.97.3 (range 1–30)
Except where indicated, data are meanSD. HDL indicates high-density lipoprotein; LDL,
low-density lipoprotein; WB-VWI, whole-brain vessel wall imaging.
*Data are the number (percentage) of patients.
Table 2. Plaque Distribution
Location
Symptomatic Side Asymptomatic Side Total
Intracranial ICA 15 (14.0) 12 (16.9) 27 (15.2)
MCA
M1 segment 52 (48.6) 36 (50.7) 88 (49.4)
M2 segment 35 (32.7) 20 (28.2) 55 (30.9)
M3 segment 4 (3.7) 1 (1.4) 5 (2.8)
ACA
A1 segment 1 (0.9) 2 (2.8) 3 (1.7)
Total 107 71 178
Data are given as number (percentage) of plaques. ACA indicates anterior cerebral
artery; ICA, internal carotid artery; MCA, middle cerebral artery.
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(OR, 6.5; 95% CI, 2.7–15.5; P<0.001), plaque-wall CR (OR,
13.4; 95% CI, 2.8–63.2; P=0.001), grade 2 contrast enhance-
ment (OR, 31.9; 95% CI, 5.9–171.9; P<0.001), plaque ER (OR,
10.0; 95% CI, 3.1–31.7; P<0.001), and type 2 enhancement
pattern (OR, 26.6; 95% CI, 5.8–121.9; P<0.001) were
individually associated with culprit lesions (Figure 4A).
According to mixed multivariable logistic regression for all
qualitative features adjusted by maximum wall thickness,
HST1 (OR, 9.1; 95% CI, 1.9–44.1; P=0.006), grade 2 contrast
enhancement (OR, 17.4; 95% CI, 1.8–164.9; P=0.013), and
type 2 enhancement pattern (OR, 10.1; 95% CI, 1.3–82.2;
P=0.030) were still independently associated with culprit
lesions (Figure 4B).
Reliability of Quantitative Measurements
A strong intraobserver reliability for maximum wall thickness,
plaque-wall CR, and lesion contrast ER was found, with
intraclass correlation coefficients (95% CIs) of 0.93 (0.88–
0.96), 0.90 (0.84–0.94), and 0.94 (0.90–0.96), respectively.
Interobserver reproducibility for the above measurements was
also excellent, with intraclass correlation coefficients (95%
CIs) of 0.87 (0.80–0.92), 0.89 (0.83–0.94), and 0.90 (0.84–
0.94), respectively.
Discussion
In this study, a group of plaque features from intracranial
atherosclerotic lesions affecting the bilateral anterior circula-
tion in patients with acute unilateral ischemic stroke were
evaluated. Our study showed that type 2 thickening/en-
hancement pattern, HST1, and grade 2 contrast enhancement
as well as the values of plaque-wall CR and plaque ER were
individually associated with culprit lesions. Furthermore, when
considered together and adjusted by maximum wall thick-
ness, HST1, grade 2 contrast enhancement, and type 2
enhancement pattern still demonstrated an independent
association with culprit lesions.
In studies of coronary22,23 and carotid24 atherosclerotic
diseases with pathologic confirmation, intraplaque hemor-
rhage (IPH) is deemed as a good predictor of ischemic events
and plaque progression. The degree of vasa vasorum invading
Table 3. Comparison of Vessel Wall Features Among 3 Types of Plaques
Variable Culprit Lesions
Probably
Culprit Lesions Nonculprit Lesions
P Value
Culprit Lesions vs
Probably Culprit Lesions
Culprit Lesions vs
Nonculprit Lesions
Probably Culprit
Lesions vs Nonculprit
Lesions
Lesion 52 (29.2) 51 (28.7) 75 (42.1)
Stenosis degree, % <0.001 <0.001 <0.001 0.066
<25 0 (0) 30 (58.8) 59 (78.7)
25–49 0 (0) 9 (17.6) 10 (13.3)
50–74 21 (40.4) 8 (15.7) 4 (5.3)
≥75 31 (59.6) 4 (7.8) 2 (2.7)
Thickening pattern <0.001 <0.001 <0.001 0.162
Type 1 12 (23.1) 36 (70.6) 61 (81.3)
Type 2 40 (76.9) 15 (29.4) 14 (18.7)
HST1 39 (75.0) 12 (23.5) 25 (33.3) <0.001 <0.001 <0.001 0.232
Plaque-wall CR* 2.01.0 1.40.4 1.40.4 <0.001 <0.001 <0.001 0.712
Enhancement degree <0.001 0.001 <0.001 0.038
Grade 0 3 (5.8) 12 (23.5) 21 (28.0)
Grade 1 23 (44.2) 30 (58.8) 51 (68.0)
Grade 2 26 (50.0) 9 (17.7) 3 (4.0)
ERplaque* 1.80.6 1.40.5 1.20.3 <0.001 <0.001 <0.001 0.006
Enhancement pattern <0.001 <0.001 <0.001 0.096
Type 1 14 (26.9) 40 (78.4) 67 (89.3)
Type 2 38 (73.1) 11 (21.6) 8 (10.7)
Except where indicated, data are the number (percentage) of lesions. All P values were estimated using a likelihood test between logistic models, with pairwise comparisons corrected
using Holm correction. CR indicates contrast ratio; ERplaque, plaque enhancement ratio; HST1, the feature characterized as high signal on T1-weighted images.
*Data are meanSD.
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from the adventitia is increased in ruptured plaques compared
with stable plaques, and microvascular incompetence is a
plausible explanation for the occurrence of IPH.22,25 Several
previous intracranial VWI studies have related HST1 to IPH
because of the fact that the major substance of IPH,
methemoglobin, has a relatively short T1 relaxation time
and, thus, appears hyperintense on T1-weighted imaging.13,16
In their work, HST1 was highly associated with ischemic
symptoms.13,16 In another study by Natori et al,18 HST1 was
believed to indicate the presence of lipid components in
addition to IPH. Nevertheless, the authors also found that
HST1 was more prevalent in the plaques of the middle
cerebral artery M1 segment ipsilateral to the acute infarcts.
Our study, with a larger cohort, showed that plaques with
HST1 were more frequently seen in culprit lesions, supporting
the relationship of HST1 and recent stroke.
Figure 1. A, Comparison of plaque-wall contrast ratio (CR) among 3 types of plaque. B, Comparison of
plaque enhancement ratio (ER) among 3 types of plaque.
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In the present study, the prevalence of HST1 was 75.0% in
culprit lesions. Xu et al13 reported HST1 in 19.6% of culprit
lesions, and Yu et al16 reported HST1 in 53.3% of culprit
lesions. Note that our definition of HST1 is based on whether
plaque-wall CR is >150%, whereas previous studies used
different criteria. This factor, combined with differential
imaging parameter settings for T1-weighted imaging, needs
to be considered when comparing the prevalence of HST1
reported herein with those reported by other studies. A
potential reason for the comparatively higher prevalence of
HST1 in our work is the substantially improved T1 contrast
weighting offered by the WB-VWI technique.20
Studies of carotid atherosclerotic plaques have suggested
that contrast enhancement of plaques is a marker of
neovascularization and inflammation.26,27 Also, a postmortem
study found that neovascularity in intracranial atherosclerotic
plaque is associated with infarct.28 Several studies of
intracranial VWI have reported that plaque enhancement
is associated with acute, subacute, and even chronic
infarction.7,15,17,29,30 We found that strong contrast enhance-
ment (grade 2) was associated with culprit lesions, likely
suggesting greater neovascularization and/or inflammation
activities in those lesions. Similarly, Qiao et al have shown
that grade 2 enhancement is associated with culprit
plaques.15 However, in their work, all the culprit and probably
culprit plaques enhanced, and 90% of the culprit plaques
showed grade 2 enhancement, demonstrating a higher
incidence than our study. This disparity may be attributable
to the different patient cohorts. Plaques in the posterior
circulation vessels were included in the analysis by Qiao
et al15 but not in ours. With the development of ICAD, definite
and frequent enhancement of the vertebral artery was
preferable because of the proliferation of vasa vasorum,31,32
which may explain the higher frequency of contrast
A
C
B
Figure 2. A 46-year-old male patient presented with right ischemic stroke. A, Axial diffusion-weighted
imaging detects a slightly high signal intensity lesion (white arrow) in the right centrum ovale. B, Time-of-
flight magnetic resonance angiography shows a severe stenosis (red arrow) in the right middle cerebral
artery (MCA) and a mild stenosis (white arrow) in the left MCA. C, Curved planar reconstruction image,
based on the precontrast whole-brain vessel wall imaging, shows a plaque with HST1 (red arrow) in the
culprit plaque of right MCA-M1. Plaques without high signal on T1-weighted images are detected in the
probably culprit plaque of the right MCA M2 segment (gold arrow) and the nonculprit plaque of the left MCA
M1 segment (white arrow).
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enhancement in culprit/probably culprit lesions and more
obvious enhancement in culprit lesions.
In the present study, type 2 thickening pattern was more
prevalent in culprit lesions. This suggests that type 2
thickening pattern may be a marker of more progressive
and extensive plaques, which may easily develop into
vulnerable plaques. This finding is in line with a previous
study, in which the authors found that asymptomatic lesions
were associated with eccentric plaques, but symptomatic
lesions were both eccentric and concentric.7 However, their
A
C
D
B
Figure 3. A 62-year-old male patient presented with right ischemic stroke. A, Axial diffusion-weighted
imaging detects high signal intensity lesions in the right basal ganglia and corona radiata. B, Time-of-flight
magnetic resonance angiography image shows a moderate stenosis on the right middle cerebral artery
(MCA)M1 segment (red arrow) and no stenosis on the left MCA. C and D, Curved planar reconstruction
images from precontrast and postcontrast whole-brain vessel wall imaging show diffuse and multiple
plaques in the right MCA and a focal plaque in the left MCA. Type 2 thickening/enhancement pattern and
obvious contrast enhancement (grade 2) are detected in the culprit plaque of the right MCA M1 segment
(red arrow). Type 1 thickening/enhancement pattern and mild contrast enhancement (grade 1) are
identified in the probable culprit plaque of the right MCA M2 segment (gold arrow) and the nonculprit
plaque of the left MCA M1 segment (white arrow).
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study included most patients with chronic stroke, which failed
to accurately reflect the association between plaque features
and acute stroke. Similar results were also found in plaque
enhancement patterns in our study. As such, type 2
enhancement pattern may reflect extensive neovasculariza-
tion or inflammatory cell infiltration, which may, in turn,
provide an indication of plaque vulnerability in culprit lesions.
Also, an independent association with culprit lesions was
observed for type 2 enhancement pattern but not for type 2
thickening pattern when features were considered together.
This underscores the value of using MR contrast medium in
characterizing plaque vulnerability.
To our best knowledge, this is the first study to explore a
group of plaque features in both quantitative and qualitative
forms among different types of plaques in a homogeneously
acute patient cohort. Although plaque features, such as HST1
and contrast enhancement, may persistent for months of
ischemic stroke,24,33–35 the short period (≤30 days) in our
study contributed to the identification of meaningful associ-
ations of the features with culprit lesions. However, there is
Figure 4. A, Odds ratio (OR) and 95% confidence interval (CI) of culprit lesions vs probably culprit
lesions or nonculprit lesions on the basis of a mixed multivariable logistic regression for each feature,
separately adjusted by maximum wall thickness. B, OR (95% CI) of culprit lesions vs probably culprit
lesions or nonculprit lesions on the basis of a mixed multivariable logistic regression for all features,
adjusted by maximum wall thickness. CR indicates contrast ratio; ER, enhancement ratio; HST1, high
signal on T1-weighted images.
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overlap in the studied features among groups. In line with
previous intracranial VWI studies, most of the qualitative
features are lacking pathologic validation. Thus, to accurately
define the characteristics of intracranial culprit lesions, the
quantitative features, including CR and ER, were analyzed in
our study. The threshold of 1.5 for CR was used to distinguish
culprit, probably culprit, and nonculprit lesions. However, this
cutoff has been used on the basis of a previous study.36
Therefore, the relative importance of HST1 and this CR cutoff
compared with other stroke risk factors should be confirmed
in a larger prospective study. On the basis of these highly
associated features, accurate identification of the culprit
lesions in patients with acute stroke may be possible,
facilitating clinicians in their treatment toward precise
secondary stroke prevention. The findings from this work
can also serve as a foundation for future investigations into
the imaging markers for high-risk plaques in patients with
asymptomatic ICAD. Early interventions aiming at these high-
risk lesions may effectively reduce the incidence of stroke.
The present study has several limitations. First, we
classified all detected plaques into 3 categories on the basis
of their stenosis degree and responsible vascular territory,
which is current clinical practice because of the lack of a true
gold standard. As a result, the assessed plaque features were
highly confounded by the lesion’s stenosis degree. However,
whether the studied features may provide complementary
information to stenosis needs to be addressed in longitudinal
studies, particularly in equivocal scenarios whereby multiple
lesions with similar stenosis degree are responsible for the
same vascular territory. Second, the study recruited patients
with strokes in the anterior circulation only. Therefore, our
conclusion has to be extrapolated to the posterior circulation
with caution, given the reported evidence about the morpho-
logical difference in plaques between the 2 vascular sites.8
Last, the features explored in this study are still limited. A
multisequence protocol, although making scan time longer,
may help extract additional useful features.
In conclusion, HST1, grade 2 contrast enhancement, and
type 2 enhancement pattern are independently associated
with culprit lesions. Detailed evaluations of these features in
symptomatic or asymptomatic patients may provide valuable
insights into risk stratification and, therefore, facilitate
preventive therapeutic interventions.
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